Biotech Values

[biotech jim]

Evogene reports 2013 results:

http://finance.yahoo.com/news/evogene-reports-fourth-quarter-end-110500959.html

"Operating loss for 2013 was $8.7 million (including a non-cash expense of $2.7 million for amortization of share-based compensation), compared to an operating loss of $3.1 million in 2012 (including a non-cash expense of $1.1 million for amortization of share-based compensation)."

Key achievements to date, as stated in the PR:

- Launch of PlaNet version 2.0 with enhanced gene stacking capabilities
- Launch of PoinTar target discovery platform for novel herbicides
- Extension and expansion of Collaboration with Monsanto
- Expansion of soybean rust resistance collaboration with DuPont-Pioneer
- Extension of soybean Nematode resistance collaboration with Syngenta
- Completion by Evofuel of three years of successful field trials for improved castor seeds in Brazil
- Successful field trial results for Black Sigatoka resistance in bananas
- Collaboration with Chinese Biotechnology Company DBN on improving key rice traits
-Launch of model plant validation system for monocot plants
-Launch of Gene2ProductTM computational ag-bio platform